Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Dyne Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DYN | Benzinga

Q: What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Dyne Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DYN.

Open	$6.95
Close	$7.04
Volume / Avg.	1.35M / 2.42M
Day Range	$6.76 - $7.14
52 Wk Range	6.36 - 47.45
Market Cap	$796.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	11.69%
Days to Cover	5.64

Recent News

Booz Allen Hamilton, Movado Group And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

JPMorgan Seeks Clarity On Dyne Therapeutics' DYNE-101 Expansion, Regulatory Path

JP Morgan analysts question Dyne Therapeutics' strategy for DYNE-101 in DM1, highlighting regulatory uncertainty and investor concerns over data updates.

Vandana Singh

Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks

BMO Capital Markets initiates coverage on Dyne Therapeutics with an Outperform rating, an $84 target, and a projected $4.3 billion peak sales for DYNE-101.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.95
Close	$7.04
Volume / Avg.	1.35M / 2.42M
Day Range	$6.76 - $7.14
52 Wk Range	6.36 - 47.45
Market Cap	$796.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	11.69%
Days to Cover	5.64

About Dyne Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and a...

Got Questions? Ask

How is the earnings season affecting DYN?

What is DYN's drawdown from recent high?

What is DYN's max drawdown this year?

What is DYN's operating cash flow?

What is DYN's P/S ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dyne Therapeutics (DYN) stock?

You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.

View our list of the best stock brokerages

Who are Dyne Therapeutics (DYN) competitors?

Other companies in Dyne Therapeutics’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), CareDx (NASDAQ:CDNA) and Day One Biopharmaceutical (NASDAQ:DAWN).

What is the forecast, or price target, for Dyne Therapeutics (DYN) stock?

Dyne Therapeutics has a consensus price target of $47.92.

What is the current price for Dyne Therapeutics (DYN)?

The stock price for Dyne Therapeutics (NASDAQ: DYN) is $7.04 last updated April 11, 2025 at 4:00 PM EDT.

Does Dyne Therapeutics (DYN) pay a dividend?

There are no upcoming dividends for Dyne Therapeutics.

When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?

Dyne Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Dyne Therapeutics (DYN) going to split?

There is no upcoming split for Dyne Therapeutics.

What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Dyne Therapeutics Stock Price, Quotes and Forecasts

Dyne Therapeutics (DYN) Forecast